Pronađeno: 1-3 / 3 radova

Autori: Reck M

>> Filter: Samo Article i Review

Naslov Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) (Meeting Abstract)
Autori Kao SCH  Reck M  Liu SV  Dziadziuszko R  Hochmair MJ  Huemer F  Gilberto de Castro J  Bernabe Caro R  Kim SH  Kowalski DM  Andric Zoran G  Oancea M  Kaul M  Li H  Danner B  Lee MC  Nabet BY  Sugawara S 
Info ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1638-S1638
Projekat F. Hoffmann-La Roche, Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100 (Meeting Abstract)
Autori Reck M  ...  Andric Zoran G  ...  (broj koautora 19) 
Info JOURNAL OF THORACIC ONCOLOGY, (2022), vol. 17 br. 9, Suppl. S, str. S39-S39
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study (Meeting Abstract)
Autori Smit E  Reck M  Krzakowski M  Gridelli C  Curescu S  Berzinec Peter  Barata F  McDermott R  Jovanovic D  Magyarlo P 
Info EJC SUPPLEMENTS, (2007), vol. 5 br. 4 , Suppl. , str. 359 -359
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX